CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates

Core Viewpoint - CVRx reported a quarterly loss of $0.53 per share, which was better than the Zacks Consensus Estimate of a loss of $0.56, and an improvement from a loss of $1.04 per share a year ago [1] Financial Performance - The company posted revenues of $12.35 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.39% and showing an increase from $10.77 million in the same quarter last year [2] - Over the last four quarters, CVRx has surpassed consensus revenue estimates three times [2] Stock Performance - CVRx shares have declined approximately 41% since the beginning of the year, compared to a decline of 4.3% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.51 on revenues of $14.78 million, and for the current fiscal year, it is -$1.95 on revenues of $58.9 million [7] Industry Outlook - The Medical - Instruments industry, to which CVRx belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]